ライフサイエンスコーパス: pluripotent stem cell

1 et production by megakaryocytes derived from pluripotent stem cells.

2 specific cell populations derived from human pluripotent stem cells.

3 mouse embryonic stem cells and human induced pluripotent stem cells.

4 al layers of global gene regulation in human pluripotent stem cells.

5 eprogramming somatic cells to become induced pluripotent stem cells.

6 ing sites in NPCs are largely preexisting in pluripotent stem cells.

7 ls of human disease to be generated-e.g., in pluripotent stem cells.

8 procedures that yield low numbers of induced pluripotent stem cells.

9 s of the miR-200 family, was detected in rat pluripotent stem cells.

10 generating chamber-specific cell types from pluripotent stem cells.

11 e in single embryonic stem cells and induced pluripotent stem cells.

12 ebral cortical spheroids (hCSs) derived from pluripotent stem cells.

13 of neurogenesis in fragile X syndrome human pluripotent stem cells.

14 ic fibroblasts are reprogrammed into induced pluripotent stem cells.

15 esenchymal transition, and the enrichment of pluripotent stem cells.

16 on of mouse embryonic stem cells and induced pluripotent stem cells.

17 us-specific DNA demethylation in somatic and pluripotent stem cells.

18 an neural progenitor cells and human induced pluripotent stem cells.

19 tion of embryonic-like structures from human pluripotent stem cells.

20 histone modifications, are a key property of pluripotent stem cells.

21 kouts in diploid or aneuploid cells, such as pluripotent stem cells, 3D organoids and cell lines, by

22 nterferes with neural specification of human pluripotent stem cells, a process equating to the earlie

23 plications of hepatocytes derived from human pluripotent stem cells and challenges to using these cel

24 generated a genetic model of PKD using human pluripotent stem cells and derived kidney organoids.

25 Dividing cells called neoblasts contain pluripotent stem cells and drive planarian flatworm rege

26 Sources include pluripotent stem cells and fetal and postnatal tissues.

27 aematopoietic stem and progenitor cells from pluripotent stem cells and holds promise for modelling h

28 Here, the authors show in induced pluripotent stem cells and mouse knockouts that RPGR med

29 viously unrecognized fate potential of human pluripotent stem cells and provides a platform for advan

30 quisition of expanded cell fate potential in pluripotent stem cells, and it represses MERVL expressio

31 The induced pluripotent stem cells approach allows comparison betwee

32 Endothelial cells derived from human pluripotent stem cells are a promising cell type for enh

33 ferentiation of four patient-derived induced pluripotent stem cells as a model for the onset of proge

34 Here, the authors use a human pluripotent stem cell-based model, termed the post-impla

35 Here we use an human-induced pluripotent stem cell-based platform to demonstrate adve

36 Here the authors apply a human pluripotent stem cell-based platform to study the effect

37 f tissue lineages can be differentiated from pluripotent stem cells by mimicking embryonic developmen

38 cells can be successfully reprogrammed into pluripotent stem cells by the ectopic expression of defi

39 ntotemporal dementia patient-derived induced pluripotent stem cell carrying the Tau P301L mutation an

40 itates the generation of more robust induced pluripotent stem cells, characterized by enhanced plurip

41 Induced pluripotent stem cells could potentially help to elucida

42 velopmental genes during the G1 phase of the pluripotent stem cell cycle contributes to cell fate dec

43 Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs)

44 K293 cells and also overexpressed in induced pluripotent stem cells derived cardiomyocytes (iPSCs-CM)

45 otent stem cells to generate a human-induced pluripotent stem cell-derived cardiac muscle patch (hCMP

46 ell device for functional screening in human pluripotent stem cell-derived cardiac organoids (hCOs).

47 onization within maturing, unlabeled induced pluripotent stem cell-derived cardiomyocyte cultures.

48 RATIONALE: Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM)

49 In human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

50 l studies of drug effects with human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

51 nd decreased beat amplitude in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

52 s to generate EHM from embryonic and induced pluripotent stem cell-derived cardiomyocytes and fibrobl

53 ed that commercially available human induced pluripotent stem cell-derived cardiomyocytes are a power

54 o supports the use of isogenic human induced pluripotent stem cell-derived cardiomyocytes as a physio

55 The patient-derived induced pluripotent stem cell-derived cardiomyocytes display (1)

56 electrophysiological maturation of the human pluripotent stem cell-derived cardiomyocytes in our syst

57 d in rodent cardiomyocytes and human induced pluripotent stem cell-derived cardiomyocytes in vitro an

58 As human pluripotent stem cell-derived cardiomyocytes remain func

59 sion produced a functional rescue in induced pluripotent stem cell-derived cardiomyocytes with D130G-

60 eded with approximately 50 000 human-induced pluripotent stem cell-derived cardiomyocytes, smooth mus

61 Using human induced pluripotent stem cell-derived cardiomyocytes, we not onl

62 ole of TLR3-IFN immunity using human induced pluripotent stem cell-derived cardiomyocytes.

63 tro models, such as isolated adult and human pluripotent stem cell-derived cardiomyocytes; (2) 2-dime

64 yocyte monolayers or small clusters of human pluripotent stem cell-derived cardiomyocytes; (3) 3-dime

65 Human and mouse pluripotent stem cell-derived CMs (PSC-CMs) were transdu

66 rat ventricular myocytes, and human induced pluripotent stem cell-derived CMs, decreasing expression

67 Transplantation of human pluripotent stem cell-derived dopaminergic neurons is a

68 ls, patient-derived fibroblasts, and induced pluripotent stem cell-derived dopaminergic neurons.

69 Here, we used comparison of induced pluripotent stem cell-derived endothelial cells (iPSC-EC

70 n the lung, our study indicates that induced pluripotent stem cell-derived endothelial cells are usef

71 Native pulmonary arterial and induced pluripotent stem cell-derived endothelial cells from pat

72 n cells, including in vitro cultured induced pluripotent stem cell-derived forebrain neurons and in v

73 xytoluene, in endocrine-active human-induced pluripotent stem cell-derived foregut epithelial cells a

74 ed the BM homing properties of human induced pluripotent stem cell-derived HSPCs (hiPS-HSPCs).

75 e in patient-derived fibroblasts and induced pluripotent stem cell-derived motor neurons.

76 H-SY5Y neuroblastoma cells and human induced pluripotent stem cell-derived motor neurons.

77 Induced pluripotent stem cell-derived neural stem cells (iNSCs)

78 Similarly, induced pluripotent stem cell-derived neurons from a patient car

79 logy of mice hippocampal neurons and induced pluripotent stem cell-derived neurons from a patient car

80 the underlying pathophysiology using induced pluripotent stem cell-derived neurons from AS patients a

81 kdown of Parkin or SLP-2, as well as induced pluripotent stem cell-derived neurons from Parkin mutati

82 agy, which is also apparent in human induced pluripotent stem cell-derived neurons, a disease-relevan

83 , but also exacerbated cell death in induced pluripotent stem cell-derived primary human neurons unde

84 stablished conditions by which human induced pluripotent stem cell-derived sensory neurons can be cul

85 expressed in either rodent or human induced pluripotent stem cell-derived sensory neurons in vitro p

86 type III neuregulin-1 (TIIINRG1) in induced pluripotent stem cell-derived sensory neurons strongly e

87 Myelinating co-cultures using human induced pluripotent stem cell-derived sensory neurons thus provi

88 ubicin-induced cytotoxicity in human induced pluripotent stem cells-derived cardiomyocytes (iPS-CMs).

89 n both mouse mesencephalic and human induced pluripotent stem cells-derived DA neurons.

90 volved mouse mesencephalic and human induced pluripotent stem cells-derived DA neurons.

91 we demonstrate that the epithelium of human pluripotent stem-cell-derived human intestinal organoids

92 Well-characterized human pluripotent stem-cell-derived ventricular cardiomyocytes

93 les and genetic screens, or applied to human pluripotent stem cell differentiation for beta-like cell

94 unique molecular mechanisms underlying human pluripotent stem cell differentiation into late primordi

95 tipotent (mesenchymal and hematopoietic) and pluripotent stem cells (embryonic and induced) for regen

96 of Nudt21 enhanced the generation of induced pluripotent stem cells, facilitated transdifferentiation

97 nable its wide application in phenotyping of pluripotent stem cells for large scale stem cell culture

98 A4 was interrupted by CRISPR-Cas9 in induced pluripotent stem cells from healthy donors.

99 Using motor neurons derived from induced pluripotent stem cells from patients with ALS and FUS mu

100 tes the self-renewing subpopulation of human pluripotent stem cells from powerful signals that drive

101 neural progenitor cells derived from induced pluripotent stem cells from schizophrenia patients with

102 ds of access to and quality of human induced pluripotent stem cells has lagged behind their use.

103 Pluripotent stem cells have broad utility in biomedical

104 Induced pluripotent stem cells have great potential as a human m

105 Treatment of patient-derived induced pluripotent stem cell-hepatic cells with a JNK inhibitor

106 G mutation to generate heteroplasmic induced pluripotent stem cell (hiPSC) clones.

107 s from families of donors into human induced pluripotent stem cell (hiPSC) lines.

108 o establish a patient-specific human induced pluripotent stem cell (hiPSC) model of CPVT2 and to use

109 The power of human induced pluripotent stem cell (hiPSC)-based studies to resolve t

110 teins with fluorescent tags in human induced pluripotent stem cells (hiPSC).

111 of cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs), 41 were accurately q

112 o generate cardiomyocytes from human induced pluripotent stem cells (hiPSCs) and human embryonic stem

113 Human induced pluripotent stem cells (hiPSCs) are invaluable to study

114 Human-induced pluripotent stem cells (hiPSCs) can be differentiated in

115 dye transfer assay showed that human induced pluripotent stem cells (hiPSCs) contained functional gap

116 can be generated in vitro from human induced pluripotent stem cells (hiPSCs) derived from patients ca

117 ac tissue (LF-ECT) composed of human induced pluripotent stem cells (hiPSCs) derived multiple lineage

118 We report the derivation of human-induced pluripotent stem cells (hiPSCs) from patients with diagn

119 Genome editing of human induced pluripotent stem cells (hiPSCs) offers unprecedented opp

120 cardiomyocyte development from human induced pluripotent stem cells (hiPSCs).

121 al human beige adipocytes from human induced pluripotent stem cells (hiPSCs).

122 cells in vitro, including from human induced pluripotent stem cells (hiPSCs).

123 Human pluripotent stem cells (hPS cells) can self-renew indefi

124 9-mediated genome editing coupled with human pluripotent stem cell (hPSC) directed differentiation.

125 e, we propose a novel approach using a human pluripotent stem cell (hPSC)-based 3D neocortical organo

126 the generation of beta-like cells from human pluripotent stem cells (hPSC).

127 an be successfully differentiated from human pluripotent stem cells (hPSCs) and hold the potential to

128 Human pluripotent stem cells (hPSCs) are adhesion-dependent ce

129 o culture complex retinal tissues from human pluripotent stem cells (hPSCs) could offer a means to st

130 As human pluripotent stem cells (hPSCs) exit pluripotency, they a

131 Cardiomyocyte creation by human pluripotent stem cells (hPSCs) has generated opportuniti

132 ar pluripotency and differentiation in human pluripotent stem cells (hPSCs) has yet to be systematica

133 testinal organoids differentiated from human pluripotent stem cells (hPSCs) have revolutionized the s

134 a platform for the differentiation of human pluripotent stem cells (hPSCs) into functional cholangio

135 e progress has been made in converting human pluripotent stem cells (hPSCs) into functional neurons.

136 We differentiated human pluripotent stem cells (hPSCs) into gastric organoids co

137 strate the capability to differentiate human pluripotent stem cells (hPSCs) into kidney structures.

138 ation of hematopoietic stem cells from human pluripotent stem cells (hPSCs) is a major goal for regen

139 Human pluripotent stem cells (hPSCs) provide a valuable model

140 Human pluripotent stem cells (hPSCs) self-organize into apicob

141 ssion level, we genetically engineered human pluripotent stem cells (hPSCs) to express various N-term

142 Here, we use human pluripotent stem cells (hPSCs) to study the dynamics of

143 es is recapitulated in differentiating human pluripotent stem cells (hPSCs), thereby providing a mode

144 lumenal epiblast-like morphogenesis of human pluripotent stem cells (hPSCs).

145 s-enduring cells were identified as distinct pluripotent stem cells in mesenchymal cell populations i

146 progenitors (PPs) can be derived from human pluripotent stem cells in vitro but efficiency of differ

147 to recapitulate the development of HSCs from pluripotent stem cells in vitro In this Review, we discu

148 s and organoids have been derived from human pluripotent stem cells in vitro, but generating a human

149 nerate functional beta-like cells from human pluripotent stem cells in vitro, including from human in

150 cells (HSCs) could be generated from induced pluripotent stem cells in vitro.

151 301 healthy individuals by the Human Induced Pluripotent Stem Cells Initiative.

152 is sufficient to differentiate human induced pluripotent stem cells into electrophysiologically activ

153 morphogen-directed differentiation of human pluripotent stem cells into haemogenic endothelium follo

154 factors can direct differentiation of human pluripotent stem cells into organoids - aggregates with

155 Technologies to differentiate human pluripotent stem cells into three-dimensional organized

156 Technology utilizing human induced pluripotent stem cells (iPS cells) has enormous potentia

157 lia tips detected in fibroblasts and induced pluripotent stem cell (iPSC) 3D optic cups derived from

158 d isogenic human RTT patient-derived induced pluripotent stem cell (iPSC) and MeCP2 short hairpin RNA

159 In RNAseq experiments of human induced pluripotent stem cell (iPSC) derived cardiomyocytes trea

160 ificantly improves the efficiency of induced pluripotent stem cell (iPSC) generation by the Yamanaka

161 type and mutant RTT patient-specific induced pluripotent stem cell (iPSC) line carrying the V247fs mu

162 is study, we derived a collection of induced pluripotent stem cell (iPSC) lines capturing a range of

163 We created induced pluripotent stem cell (iPSC) lines from 1 patient with t

164 ne expression profiling of 215 human induced pluripotent stem cell (iPSC) lines from different donors

165 three C1 replicates from three human induced pluripotent stem cell (iPSC) lines.

166 in three wild-type (WT) and three HD induced-pluripotent stem cell (iPSC) lines.

167 While induced pluripotent stem cell (iPSC) technologies enable the stu

168 Human-induced pluripotent stem cell (iPSC) technology offers a novel p

169 rain specimens, we took advantage of induced pluripotent stem cell (iPSC) technology to model the dis

170 was significantly upregulated in SMA induced pluripotent stem cell (iPSC)-derived astrocytes and SMND

171 ten the action potential duration in induced pluripotent stem cell (iPSC)-derived cardiomyocytes from

172 d the therapeutic potential of human induced pluripotent stem cell (iPSC)-derived cells at two differ

173 related genetic mutations in patient induced pluripotent stem cell (iPSC)-derived DAergic neurons and

174 We studied induced-pluripotent stem cell (iPSC)-derived megakaryocytes (iMe

175 In neuropathology research, induced pluripotent stem cell (iPSC)-derived neurons are conside

176 he innate immune properties of human induced-pluripotent stem cell (iPSC)-derived RPE cells, particul

177 engineered blood vessel (TEBV) using induced pluripotent stem cell (iPSC)-derived SMCs from an HGPS p

178 In recent years, rapid emergence of induced pluripotent stem cells (iPSC) and iPSC-derived cardiomyo

179 ate oligodendrocytes (OL) from human induced pluripotent stem cells (iPSC) are currently lacking, but

180 Donor-specific induced pluripotent stem cells (iPSC) can be used to generate de

181 We have generated induced pluripotent stem cells (iPSC) from five HLHS patients an

182 report the differentiation of human induced pluripotent stem cells (iPSC) into microglia-like cells

183 complex (TSC) and LAM (TSC-LAM) into induced pluripotent stem cells (iPSC), followed by selection of

184 d body (EB) cells] from primed-state induced pluripotent stem cells (iPSCs) after a 72-hour transient

185 Two recent technologies, induced-pluripotent stem cells (iPSCs) and direct somatic reprog

186 complex processes: reprogramming to induced pluripotent stem cells (iPSCs) and hematopoiesis.

187 1) and used their tissue to generate induced pluripotent stem cells (iPSCs) and hepatocyte-like cells

188 ing neurons derived from PWS patient induced pluripotent stem cells (iPSCs) and mouse models, the aut

189 Here, we used induced pluripotent stem cells (iPSCs) and neural progenitor cel

190 Induced pluripotent stem cells (iPSCs) are an essential tool for

191 Induced pluripotent stem cells (iPSCs) are being pursued as a so

192 Human induced pluripotent stem cells (iPSCs) are ideal cell sources fo

193 ntotemporal dementia patient-derived induced pluripotent stem cells (iPSCs) carrying the Tau P301L mu

194 Human induced pluripotent stem cells (iPSCs) derived from individuals

195 murine and human retinoblastomas and induced pluripotent stem cells (iPSCs) derived from murine rod p

196 Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) efficiently generate all

197 We generated and characterized induced pluripotent stem cells (iPSCs) from ALS patients with di

198 In this study, we generated induced pluripotent stem cells (iPSCs) from AML patient samples

199 We generated induced pluripotent stem cells (iPSCs) from control individuals

200 Here we generated de novo induced pluripotent stem cells (iPSCs) from patients harboring t

201 opment, the present study used human induced pluripotent stem cells (iPSCs) from RTT and control indi

202 Genome integrity of induced pluripotent stem cells (iPSCs) has been extensively stud

203 Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) holds enormous promise fo

204 n leukocyte antigen (HLA)-homozygous-induced pluripotent stem cells (iPSCs) is considered a future cl

205 ramming of differentiated cells into induced pluripotent stem cells (iPSCs) is usually achieved by ex

206 Induced pluripotent stem cells (iPSCs) show variable methylation

207 w that astrocytes derived from human induced pluripotent stem cells (iPSCs) support the replication o

208 ed on a genetically diverse panel of induced pluripotent stem cells (iPSCs) that reproduces susceptib

209 variants through differentiation of induced pluripotent stem cells (iPSCs) to study cellular pathoph

210 Steering the differentiation of induced pluripotent stem cells (iPSCs) toward specific cell type

211 ganoids derived from control and MDS-induced pluripotent stem cells (iPSCs) using time-lapse imaging,

212 Induced pluripotent stem cells (iPSCs) were generated from one u

213 s derived from schizophrenia patient induced pluripotent stem cells (iPSCs) with a DISC1 mutation tha

214 of functional airway organoids from induced pluripotent stem cells (iPSCs) would provide valuable mo

215 Induced pluripotent stem cells (iPSCs), and cells derived from t

216 knockdown neuroblastoma cell lines, induced pluripotent stem cells (iPSCs), and iPSC-derived cortica

217 We show that during reprogramming to induced pluripotent stem cells (iPSCs), fibroblasts from sterile

218 blished a liver organoid using human induced pluripotent stem cells (iPSCs), mesenchymal stem cells (

219 Using patient-specific induced pluripotent stem cells (iPSCs), we generated MCT8-defici

220 , stem cells as well as reprogrammed induced pluripotent stem cells (iPSCs), where the protein can al

221 characteristics can be produced from induced pluripotent stem cells (iPSCs).

222 (OSKM) reprograms somatic cells into induced pluripotent stem cells (iPSCs).

223 uman embryonic stem cells (hESCs) or induced pluripotent stem cells (iPSCs).

224 erm that has been derived from human induced pluripotent stem cells (iPSCs).

225 and clinical interest, such as human induced pluripotent stem cells (iPSCs).

226 six transformed cell lines and human induced pluripotent stem cells (iPSCs).

227 ming by transcription factors (i.e., induced pluripotent stem cells, iPSCs) or by somatic cell nuclea

228 using macrophages derived from human induced pluripotent stem cells (iPSdMs) to study macrophage-Chla

229 s from human embryonic stem cells or induced pluripotent stem cells is at present close to reality, a

230 apitulates disease-relevant phenotypes using pluripotent stem cells lacking TREX1.

231 ed from multiple human embryonic and induced pluripotent stem cell lines and have potential applicati

232 ain cell fates, our fragile X syndrome human pluripotent stem cell lines exhibited reproducible aberr

233 rkinson's Disease, we have generated induced Pluripotent Stem Cell lines from early onset Parkinson's

234 ing large-scale collections of human induced pluripotent stem cell lines provide valuable insight int

235 Isogenic induced pluripotent stem cell lines showed greater variability i

236 more common in ES cell lines than in induced pluripotent stem cell lines.

237 et al. (2017) investigate mechanisms for how pluripotent stem cells maintain their identity during ce

238 The advent of induced pluripotent stem cells means that it may ultimately be p

239 2 hiPSC lines and 2 hESC lines at 4 stages: pluripotent stem cells, mesoderm, cardiac mesoderm, and

240 a vascular model derived from human induced pluripotent stem cells (MFS-hiPSCs).

241 ancreatic endocrine cells derived from human pluripotent stem cells mimics key in vivo events.

242 ndromic autism pathophysiology using induced pluripotent stem cells modeling disease technology.

243 Here we show, using murine and human induced pluripotent stem cell models, that RPGR interacts with a

244 reprogrammed fibroblasts to generate induced pluripotent stem cells, neural progenitor cells (NPCs) a

245 broblasts, embryonic stem cells, and induced pluripotent stem cells of laboratory rats.

246 evertheless, to our knowledge, miRNAs in the pluripotent stem cells of one of the most commonly used

247 Induced pluripotent stem cells offer a new way to recapitulate p

248 ty to propagate mature cells and tissue from pluripotent stem cells offers enormous promise for treat

249 human neural progenitor cells, human induced pluripotent stem cells, or in primary rat cortical neuro

250 etal muscle efficiently from porcine induced pluripotent stem cells (piPSC) in vitro thereby providin

251 mechanism for controlling the make-up of the pluripotent stem cell population.

252 Human pluripotent stem cells provide a potential source for ph

253 ables organ-specific enrichment of xenogenic pluripotent stem cell (PSC) derivatives.

254 Through pluripotent stem cell (PSC) technology, human intestinal

255 several groups pursuing clinical trials with pluripotent stem cell (PSC)-derived dopamine neurons.

256 LA) class I genes can cause the rejection of pluripotent stem cell (PSC)-derived products in allogene

257 problem that is particularly encountered in pluripotent stem cells (PSCs) and their differentiated p

258 Patient-specific pluripotent stem cells (PSCs) can be generated via nucle

259 Human pluripotent stem cells (PSCs) exist in naive and primed

260 stem and progenitor cells (HSPCs) from human pluripotent stem cells (PSCs) has been a long-sought-aft

261 Pluripotent stem cells (PSCs) have major potential as an

262 isms, have been challenging to generate from pluripotent stem cells (PSCs) in part because there are

263 opmentally differentiated NKX2-1GFP reporter pluripotent stem cells (PSCs) in vitro to generate and i

264 Approaches to differentiating pluripotent stem cells (PSCs) into neurons currently fac

265 The generation of T cells from pluripotent stem cells (PSCs) is attractive for investig

266 neered by either directed differentiation of pluripotent stem cells (PSCs) or direct conversion, and

267 Human pluripotent stem cells (PSCs) provide a unique entry to

268 Of all known cultured stem cell types, pluripotent stem cells (PSCs) sit atop the landscape of

269 The in vitro-directed differentiation of pluripotent stem cells (PSCs) through stimulation of dev

270 tion has focussed on the conversion of human pluripotent stem cells (PSCs) to a more naive developmen

271 In order for pluripotent stem cells (PSCs) to appropriately respond t

272 ineering approach with embryonic and induced pluripotent stem cells (PSCs) to generate human intestin

273 sis of BMP4-induced differentiation of human pluripotent stem cells (PSCs) toward progeny with trophe

274 novo methylation of the entire CGI in human pluripotent stem cells (PSCs).

275 pitulating skeletal myogenesis in vitro from pluripotent stem cells (PSCs).

276 t to which in vitro differentiation of human pluripotent stem cells recapitulates bona fide human dev

277 Differentiation of human pluripotent stem cells recapitulates development of the

278 Here, we use human induced pluripotent stem cell-retinal pigment epithelium (hiPSC-

279 d differentiation of patient-derived induced pluripotent stem cells showed a reduced expansion of lym

280 ociation Studies Consortium has used induced pluripotent stem cell technology to study the effects of

281 ion of arterial endothelial cells from human pluripotent stem cells that exhibit arterial-specific fu

282 erate three-dimensional spheroids from human pluripotent stem cells that resemble either the dorsal o

283 nto three domains: the lineage commitment of pluripotent stem cells, the appropriation of primordial

284 hat are derived from mouse and human induced pluripotent stem cells through a mechanism that involves

285 m with NPCs and neurons derived from induced pluripotent stem cells to create patient-specific cellul

286 t had been differentiated from human-induced pluripotent stem cells to generate a human-induced pluri

287 We used fibroblast-derived induced pluripotent stem cells to generate retinal pigment epith

288 we report a method for differentiating human pluripotent stem cells to inner ear organoids that harbo

289 For example, attempts to differentiate human pluripotent stem cells to lung epithelium rely on passin

290 Applying Expedition to single pluripotent stem cells undergoing neuronal differentiati

291 Induced pluripotent stem cells were derived from a clinically we

292 Whole-genome sequencing and induced pluripotent stem cells were used to examine a family wit

293 ted CSC-like cells by treating mouse induced pluripotent stem cells with conditioned medium from brea

294 at human cardiomyocytes derived from induced pluripotent stem cells with enhanced expression of isofo

295 th human cardiomyocytes derived from induced pluripotent stem cells with enhanced Kir2.1 expression a

296 ngs constitute a first step toward capturing pluripotent stem cells with extraembryonic developmental

297 titative single-cell analyses, we found that pluripotent stem cells with naturally short G1 phases lo

298 to a selection of biological systems: human pluripotent stem cells with their cardiac derivatives, m

299 an extra human chromosome and human induced pluripotent stem cells with trisomy 21, as well as cance

300 expands the developmental potential of mouse pluripotent stem cells, yielding both embryonic and extr